C-reactive protein and neutrophil-lymphocyte ratio are prognostic in metastatic clear-cell renal cell carcinoma patients treated with nivolumab

Eduard Roussel; Lisa Kinget; Annelies Verbiest; Philip R. Debruyne; Marcella Baldewijns; Hendrik Van Poppel; Maarten Albersen; Benoit Beuselinck

doi:10.1016/j.urolonc.2020.12.020

C-reactive protein and neutrophil-lymphocyte ratio are prognostic in metastatic clear-cell renal cell carcinoma patients treated with nivolumab

Eduard Roussel
, Lisa Kinget
, Annelies Verbiest
, Philip R. Debruyne
, Marcella Baldewijns
, Hendrik Van Poppel
, Maarten Albersen
, Benoit Beuselinck

School of Nursing and Midwifery

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	239.e17-239.e25
Journal	Urologic Oncology: Seminars and Original Investigations
Volume	39
Issue number	4
Early online date	21 Jan 2021
DOIs	https://doi.org/10.1016/j.urolonc.2020.12.020
Publication status	Published - 1 Apr 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/j.urolonc.2020.12.020

https://linkinghub.elsevier.com/retrieve/pii/S1078143920306499

Cite this

Roussel, E., Kinget, L., Verbiest, A., Debruyne, P. R., Baldewijns, M., Van Poppel, H., Albersen, M., & Beuselinck, B. (2021). C-reactive protein and neutrophil-lymphocyte ratio are prognostic in metastatic clear-cell renal cell carcinoma patients treated with nivolumab. Urologic Oncology: Seminars and Original Investigations, 39(4), 239.e17-239.e25. https://doi.org/10.1016/j.urolonc.2020.12.020

@article{e5abb87f0caa4af0aee9f304b7943d75,

title = "C-reactive protein and neutrophil-lymphocyte ratio are prognostic in metastatic clear-cell renal cell carcinoma patients treated with nivolumab",

author = "Eduard Roussel and Lisa Kinget and Annelies Verbiest and Debruyne, \{Philip R.\} and Marcella Baldewijns and \{Van Poppel\}, Hendrik and Maarten Albersen and Benoit Beuselinck",

year = "2021",

month = apr,

day = "1",

doi = "10.1016/j.urolonc.2020.12.020",

language = "English",

volume = "39",

pages = "239.e17--239.e25",

journal = "Urologic Oncology: Seminars and Original Investigations",

issn = "1078-1439",

publisher = "Elsevier Inc.",

number = "4",

}

Roussel, E, Kinget, L, Verbiest, A, Debruyne, PR, Baldewijns, M, Van Poppel, H, Albersen, M & Beuselinck, B 2021, 'C-reactive protein and neutrophil-lymphocyte ratio are prognostic in metastatic clear-cell renal cell carcinoma patients treated with nivolumab', Urologic Oncology: Seminars and Original Investigations, vol. 39, no. 4, pp. 239.e17-239.e25. https://doi.org/10.1016/j.urolonc.2020.12.020

C-reactive protein and neutrophil-lymphocyte ratio are prognostic in metastatic clear-cell renal cell carcinoma patients treated with nivolumab. / Roussel, Eduard; Kinget, Lisa; Verbiest, Annelies et al.
In: Urologic Oncology: Seminars and Original Investigations, Vol. 39, No. 4, 01.04.2021, p. 239.e17-239.e25.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - C-reactive protein and neutrophil-lymphocyte ratio are prognostic in metastatic clear-cell renal cell carcinoma patients treated with nivolumab

AU - Roussel, Eduard

AU - Kinget, Lisa

AU - Verbiest, Annelies

AU - Debruyne, Philip R.

AU - Baldewijns, Marcella

AU - Van Poppel, Hendrik

AU - Albersen, Maarten

AU - Beuselinck, Benoit

PY - 2021/4/1

Y1 - 2021/4/1

U2 - 10.1016/j.urolonc.2020.12.020

DO - 10.1016/j.urolonc.2020.12.020

M3 - Article

SN - 1078-1439

VL - 39

SP - 239.e17-239.e25

JO - Urologic Oncology: Seminars and Original Investigations

JF - Urologic Oncology: Seminars and Original Investigations

IS - 4

ER -